-
-
-
-
-
-
-
Scotiabank Downgrades Sage Therapeutics (SAGE) to Sector Perform
-
-
-
-
-
-
-
Grabar Law Office Investigates Claims on Behalf of Shareholders of Sage Therapeutics, Inc. (SAGE)
-
-
-
-
-
-
-
SAGE Therapeutics (SAGE) Explores Strategic Alternatives
-
-
-
-
-
-
-
RBC Capital Upgrades Sage Therapeutics (SAGE) to Sector Perform
-
-
-
-
-
-
-
SAGE Therapeutics (SAGE) Announces Strategic Reorganization to Prioritize ZURZUVAE Commercialization and Focus its Development Portfolio
-
-
-
-
-
-
-
SAGE Therapeutics (SAGE) Announces Discontinuation of the Collaboration with Biogen on the SAGE-324 Program
-
-
-
-
-
-
-
SAGE Therapeutics (SAGE) Misses Q2 EPS by 6c
-
483,199 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All


